Position in TMO
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$6,991,966
+$228,022 QoQ
Shares Held
13,946
+1.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#745
of 2,602 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tema ETFs LLC holds $20,010,707 across 13 Diagnostics & Research names. TMO ranks #1 (34.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
13,946 | $6,991,966 | |
| 2 | DHR |
Danaher Corp /De/
|
19,114 | $3,640,834 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
3,934 | $2,071,014 | |
| 4 | GH |
Guardant Health, Inc.
|
10,986 | $1,648,229 | |
| 5 | WAT |
Waters Corp /De/
|
4,030 | $1,511,411 | |
| 6 | NTRA |
Natera, Inc.
|
4,238 | $1,150,405 | |
| 7 | A |
Agilent Technologies, Inc.
|
5,060 | $672,119 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
3,370 | $651,151 |
All Filings in TMO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,991,966 | 13,946 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $6,763,944 | 13,761 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $8,265,854 | 14,265 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $6,798,040 | 14,016 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,624,542 | 6,473 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,343,374 | 6,719 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,318,262 | 2,534 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||